Husfasad, Nya St Eriks Ögonsjukhus

Division of Eye and Vision

The Division of Eye and vision which is located at St. Erik Eye Hospital, conducts education at the undergraduate, advanced and postgraduate levels, as well as research with the aim of developing the eye care of the future.

Photo: Arkitektillustration
illustration of a hand holding a looking glass over a brain. Photo: Pixabay,Mohamed Hassan

Pete Williams awarded grant from the Swedish Brain Foundation

Each year, the Swedish Brain Foundation supports qualified research on the brain and other nervous systems, as well as diseases, injuries, and disabilities throughout the nervous system. 

Pete Williams, researcher at Karolinska Institutet and St. Erik Eye Hospital, has been awarded a research grant from the Swedish Brain Foundation for his project: "NAD metabolism as a target for neuroprotection in age-related ophthalmic and neurodegenerative diseases".

The grant, which amounts to SEK 2.4 million, will fund the research over a three-year period.

 

 

Retina – Anders Kvanta's research group

Ocular Oncology and Pathology – Gustav Stålhammar's research group

Photo: Jens Sølvberg

Gustav Stålhammar, nominated as one of the emerging and promising young researchers from the Nordic countries.

Acta Board have been nominated Gustav Stålhammar as one of the emerging and promising young researchers from the Nordic countries.

followed by a session with four young speakers from the Scandinavian countries, each of whom will talk about their own research. We invite you to be one of these speakers.

On the occasion of the 100th of Acta anniversary in Maastricht in June, Gustav is invited together with Joni Turunen, Finland och Cecilie Bredrup, Norway to speak about their own research.

Title of Gustavs lecture is: ”Uveal melanoma past, present, and future -Towards adjuvant treatment”

Ocular Oncology and Pathology

Select an option
Development and Validation of a Deep Learning Algorithm for Differentiation of Choroidal Nevi from Small Melanoma in Fundus Photographs Tailoring surveillance imaging in uveal melanoma based on individual metastatic risk Melatonin Receptor Expression in Primary Uveal Melanoma The prognostic implication of visual acuity at the time of uveal melanoma diagnosis Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death Digital morphometry and cluster analysis identifies four types of melanocyte during uveal melanoma progression Overrepresentation of human epidermal growth factor receptor2 positive- and Luminal B breast cancer metastases in the eyesand orbit Improved Staging of Ciliary Body and Choroidal Melanomas Based on Estimation of Tumor Volume and Competing Risk Analyses Sex-based differences in early and late uveal melanoma-related mortality No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter Gain of Chromosome 6p Correlates with Severe Anaplasia, Cellular Hyperchromasia, and Extraocular Spread of Retinoblastoma Risk for Acute Myocardial Infarction After Ophthalmologic Procedures The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis Brachytherapy With 15- Versus 20-mm Ruthenium 106 Plaques Without Verification of Plaque Position Is Associated With Local Tumor Recurrence and Death in Posterior Uveal Melanoma Obesity paradox in uveal melanoma: high body mass index is associated with low metastatic risk Multiorgan Involvement of Dormant Uveal Melanoma Micrometastases in Postmortem Tissue From Patients Without Coexisting Macrometastases A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival Adjuvant melatonin for uveal melanoma (AMUM): protocol for a randomized open-label phase III study Melatonin Receptor Expression in Primary Uveal Melanoma Prognostic implications of tenascin C in peripheral blood and primary tumours at the time of uveal melanoma diagnosis

Eye movements and vision – Tony Pansell's research group

Vision impairment is common in non-hospitalised patients with post-COVID-19 syndrome

Vision-related symptoms and impairments were prevalent in the study group. The Developmental Eye Movement Test and the Visual Motion Sensitivity Clinical Test Protocol showed promise for clinical assessment of saccadic performance and sensitivity to movement in the environment. Further study will be required to explore the utility of these tools.

Glaucoma – Pete Williams' research group

illustration of a hand holding a looking glass over a brain. Photo: Pixabay,Mohamed Hassan

Pete Williams awarded grant from the Swedish Brain Foundation

Each year, the Swedish Brain Foundation supports qualified research on the brain and other nervous systems, as well as diseases, injuries, and disabilities throughout the nervous system. 

Pete Williams, researcher at Karolinska Institutet and St. Erik Eye Hospital, has been awarded a research grant from the Swedish Brain Foundation for his project: "NAD metabolism as a target for neuroprotection in age-related ophthalmic and neurodegenerative diseases".

The grant, which amounts to SEK 2.4 million, will fund the research over a three-year period.

 

 

Glaucoma

More publications

Select an option
Excitatory and inhibitory neurotransmitter alterations with advancing age and injury in the mouse retina Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again) Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma NMNAT2 is a druggable target to drive neuronal NAD production Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume Umeå i topp i VR-medel till klinisk behandlingsforskning Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma Valproic Acid Reduces Neuroinflammation to Provide Retinal Ganglion Cell Neuroprotection in the Retina Axotomy Model Diploma for best essay has been awarded to: Albin Camitz and supervisor James Tribble Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering Nicotinamide Prevents Retinal Vascular Dropout in a Rat Model of Ocular Hypertension and Supports Ocular Blood Supply in Glaucoma Patients NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve Retinal ganglion cell repopulation for vision restoration in optic neuropathy: a roadmap from the RReSTORe Consortium